Cite
HARVARD Citation
Bertani, L. et al. (n.d.). OC.09.4 FECAL CALPROTECTIN COULD PREDICT MUCOSAL HEALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH VEDOLIZUMAB: A PROSPECTIVE SINGLE-CENTER STUDY. Digestive and liver disease. pp. e101-. [Online].